Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
about
Use of dry powder inhalers in acute exacerbations of asthma and COPD.Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.Budesonide/formoterol in the treatment of asthma.Dry-powder inhalers in acute asthma.Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.
P2860
Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differences in the pharmacodyn ...... rapeutic usefulness in asthma.
@en
Differences in the pharmacodyn ...... rapeutic usefulness in asthma.
@nl
type
label
Differences in the pharmacodyn ...... rapeutic usefulness in asthma.
@en
Differences in the pharmacodyn ...... rapeutic usefulness in asthma.
@nl
prefLabel
Differences in the pharmacodyn ...... rapeutic usefulness in asthma.
@en
Differences in the pharmacodyn ...... rapeutic usefulness in asthma.
@nl
P2860
P356
P1476
Differences in the pharmacodyn ...... rapeutic usefulness in asthma.
@en
P2093
Bertil Lindmark
P2860
P304
P356
10.1177/1753465808096135
P577
2008-09-18T00:00:00Z